In the AFFIRM trial, elderly patients (mean age, 70; 61% men) with minimally symptomatic atrial fibrillation (AF) and high risk for stroke were randomized to either a rate-control or a rhythm ...

The caveat here is that if one is opting for rhythm control to avoid the need for warfarin in this elderly population, that is not a valid assumption. How should one manage atrial fibrillation ...

Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.

the findings emphasize the importance of aggressive AFib management, particularly in younger patients who might otherwise receive less intensive treatment due to their age. Rhythm control ...

Stroke, one of the most severe complications of atrial fibrillation (AF), can be prevented by oral anticoagulants in patients ...

a “rate control” strategy and a “rhythm control” strategy. In 2002, the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) randomized trial evaluated the outcomes of ...

Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...

(European Journal of Preventive Cardiology) The available observational data point to dronedarone being better than sotalol as a first-line anti-arrhythmic drug for rhythm control in Afib.

Atrial fibrillation (AFib) is the most common abnormal heart rhythm found in our community. According to the CDC website, an estimated 12 million people in the United States will have atrial ...

There are improved all-cause mortality, rhythm control, and adverse cardiac event outcomes in patients being treated with tirzepatide who have atrial fibrillation. Patients with atrial ...